Media

News

Are you a media representative looking for content on Bayer? This section provides access to media releases as well as feeds from our social media channels.

 

Bayer Inc. investing $500,000 in STEM education for Canadian youth through Let’s Talk Science
Bayer’s darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival by 22 months, with a favourable safety profile compared to placebo plus ADT in non-metastatic castration-resistant prostate cancer
Does your community charity need some TLC?
China grants regulatory approval of TruFlex™ canola with Roundup Ready® Technology